CSIMarket Company Name, Ticker, Competitors, else..
 
Avricore Health Inc   (VANC)
Other Ticker:  
 
 
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 100
 Employees 12
 Revenues (TTM) (Millions $) 2
 Net Income (TTM) (Millions $) -1
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 1

Avricore Health Inc
Avricore Health Inc is a Canadian healthcare technology company focused on delivering personalized medicine to individuals. The company specializes in developing and commercializing innovative solutions that enable real-time monitoring, detection, and management of chronic diseases. Avricore Health's flagship product is the HealthTab system, a point-of-care blood testing platform that provides individuals with access to lab-quality results within minutes. This technology empowers individuals to track their health metrics and take proactive steps to improve their well-being. Avricore Health aims to revolutionize healthcare by leveraging digital technologies to provide personalized, convenient, and cost-effective healthcare solutions.


   Company Address: 1120 ? 789 West Pender Street Vancouver 0 BC
   Company Phone Number: 773-8943   Stock Exchange / Ticker: VANC


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
NGNE      % 
SRPT      % 
BLGO   -5%    
FLGT        6.39% 
THRM        6.39% 
• View Complete Report
   



Unity Biotechnology Inc

The Major Pharmaceutical Preparations company added some great scenario for the investors, presenting a relevant growth in January to March 31 2025 with operating shortfall of $-6.891 million

The investors have not assumed any adjustments at the revenue throughout the the January to March 31 2025 reporting cycle at the UBX. But, they pay very near attention to the company's operating shortfall which came in at $-6.891 million, in the same period.

Bioadaptives Inc

Observing the fourth quarter of 2024 results, the company's saw top-line has dropped by -88.085 %

For the fiscal fourth quarter of 2024 company reached break-even of $0.00 per share compare to $0.00 a year before and from $0.00 per share from the previous reporting period. The revenue fell sharply to $0.00 million from $0.01 million in the same reporting period a year before and sequentially from $0.00 million.

Transcode Therapeutics Inc

The Major Pharmaceutical Preparations company published operating loss of $-5.092387 million, in the October to December 31 2024 time-frame

While the October to December 31 2024 reporting cycle resumes, many companies have reported the respective earnings. In the thick of it, have been various entities in the Major Pharmaceutical Preparations sector. As well as, now, Transcode Therapeutics Inc reported operating loss of $-5.092387 million, for the October to December 31 2024 time-frame.

Eyenovia Inc

The Deficit has widen more at the Major Pharmaceutical Preparations company amid the October to December 31 2024 financial time-frame

Eyenovia Inc announced very solid Revenue rise year on year to $0.03 million in the October to December 31 2024 span, but increased a deficit per share at $-59.26.

Vaccinex Inc

The company announced Revenue of $0.199 million, in the fiscal interval ending December 31 2024

Vaccinex Inc has seen $0.199 million, in Revenue in the fourth quarter of 2024.










Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com